Tepnel buys Orchid Biosciences

That's a bit more like it ;-)



Abcam plc (AIM: ABC), the rapidly growing company that markets antibodies via an
online catalogue, is pleased to announce that it has signed a global licensing
agreement with Tepnel Life Sciences PLC ("Tepnel") (AIM: TED), the UK-based
international molecular diagnostics and research products & services group, for
the distribution of Tepnel's Diaclone range of diagnostic and research products.



The Diaclone range includes more than 350 immunological products designed for
therapy, diagnostic and research applications. The distribution partnership
with Tepnel is an exclusive agreement for sales in Japan, Canada, and South
America. In the USA Abcam will share the sales rights for the Diaclone range
with Tepnel. The sales arrangement is non-exclusive elsewhere in the world.



As part of the agreement Abcam will give Tepnel an upfront payment and has
guaranteed to a minimum level of annual sales.